← Eichor
Study identifier: NCT06735105 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Study on the Value of Three DWI Scanning Sequences in Staging of Gastric Cancer

Condition: Gastric Cancer  ·  Sponsor: Yunnan Cancer Hospital

PhaseNA
Planned participants129
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersYes

About this study

Accurate staging is critical for effective gastric cancer treatment planning. Conventional DWI (C-DWI) has limitations in image quality due to magnetic field inhomogeneity, which hampers precise T staging. This study aims to compare the image quality and T staging accuracy of C-DWI, TSE-DWI, and ZOOMit-DWI (Z-DWI) sequences in MRI examinations of gastric cancer patients. A prospective study plan to enroll 72 gastric cancer patients undergoing preoperative MRI with C-DWI, TSE-DWI, and Z-DWI sequences using a 3.0 T scanner. Quantitative metrics (ADC, SNR, CNR) and image quality were evaluated. T staging accuracy was assessed by comparing MRI results with postoperative pathological staging using ROC analysis.

This description comes directly from the study's public registry record.

Talk to the study team

Li Yanli, master  ·  18987958050  ·  lyl2241@163.com

Li Zhenhui, MD  ·  13698736132  ·  lizhenhui@kmmu.edu.cn

Always discuss trial participation with your own doctor first.

Locations (1)

Yunnan Cancer HospitalKunming, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06735105